Pharmacodynamics modeling to optimize dosage regimens of sulbactam

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3441-3444

  Jaruratanasirikul, Sutep ^a   Wongpoowarak, Wibul ^a   Aeinlang, Nanchanit ^a   Jullangkoon, Monchana ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

SIBATAM; SULBACTAM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MINIMUM INHIBITORY CONCENTRATION; MONTE CARLO METHOD; NORMAL HUMAN; PRIORITY JOURNAL; PROBABILITY; SIMULATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MONTE CARLO METHOD; SULBACTAM; YOUNG ADULT;

EID: 84879014715     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00342-13     Document Type: Article

References (17)

1. Mahgoub S, Ahmed J, Glatt AE. 2002. Completely resistant Acinetobacter baumannii strains. Infect. Control. Hosp. Epidemiol. 23:477-479.
2. Hsueh PR, Teng LJ, Chen CY, Chen WH, Ho SW, Luh KT. 2002. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg. Infect. Dis. 8:827-832.
3. Williams JD. 1997. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin. Infect. Dis. 24:494-497. (Pubitemid 27096809)
4. Rodríguez-Hernández MJ, Cuberos L, Pichardo C, Caballero FJ, Moreno I, Jiménez-Mejías ME, García-Curiel A, Pachón J. 2001. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J. Antimicrob. Chemother. 47: 479-482. (Pubitemid 32303419)
5. Wildfeuer A, Räder K. 1996. Stability of β-lactamase inhibitors and β-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin. Int. J. Antimicrob. Agents 6:S31-S34. (Pubitemid 126657466)
6. Bawdon RE, Madsen PO. 1986. High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob. Agents Chemother. 30:231-233. (Pubitemid 16038753)
7. Jaruratanasirikul S, Wongpoowarak W, Kositpantawong N, Aeinlang N, Jullangkoon M. 2012. Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia. Int. J. Antimicrob. Agents 40:434-439.
8. Mathews JH. 1987. Numerical methods for computer science, engineering, and mathematics. Prentice-Hall International, Inc., London, United Kingdom.
9. Li J, Rhinehart RR. 1998. Heuristic random optimization. Computers Chem. Eng. 22:427-444. (Pubitemid 128644786)
10. Worakul N, Wongpoowarak W, Boonme P. 2002. Optimization in development of acetaminophen syrup formulation. Drug Dev. Ind. Pharm. 28:345-351. (Pubitemid 34475681)
11. Box GEP, Muller ME. 1958. A note on the generation of random normal deviates. Ann. Math. Stat. 29:610-611.
12. Rolinson GN, Sutherland R. 1965. The binding of antibiotics to serum proteins. Br. J. Pharmacol. 25:638-650.
13. Craig WA. 1995. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22:89-96.
14. Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig WA. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.
15. Drusano GL. 2003. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin. Infect. Dis. 36(Suppl. 1):S42-S50. (Pubitemid 36140468)
16. Betrosian AP, Frantzeskaki F, Xanthaki A, Georgiadis G. 2007. Highdose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scand. J. Infect. Dis. 39:38-43. (Pubitemid 46277146)
17. Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE. 2008. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. J. Infect. 56:432-436.